```html

Ophthalmic Herpes Simplex – Comprehensive Medical Guide

Overview

Ophthalmic herpes simplex (HSE) is an infection of the eye caused primarily by Herpes simplex virus type 1 (HSV‑1), and less frequently by HSV‑2. The virus can affect any ocular structure, from the eyelid skin to the cornea, conjunctiva, and even the inner eye (uvea). When the virus involves the cornea, the condition is often called herpes keratitis, the most common cause of infectious blindness in the United States and many industrialized nations.

Who it affects

• All ages can be infected, but severe eye disease most commonly appears in adults aged 20‑50.
• People with a history of oral or genital herpes are at higher risk for ocular involvement.
• Immunocompromised individuals (e.g., HIV infection, organ‑transplant recipients, patients on systemic steroids) have a greater likelihood of recurrent or severe disease.

Prevalence

• Worldwide, ≈ 67% of the population is seropositive for HSV‑1, but only <5% develop ocular disease [CDC].
• In the United States, an estimated 500,000–700,000 new cases of herpes keratitis occur each year, making it the leading cause of corneal blindness in developed countries [Mayo Clinic].
• Recurrence rates after an initial episode range from 30–50% within five years, especially without long‑term antiviral prophylaxis.

Symptoms

Symptoms vary based on which ocular structures are involved and whether the infection is primary (first exposure) or recurrent. Below is a complete list, grouped by location.

Eyelid (herpes simplex blepharitis)

• Redness and swelling of the eyelid margin.
• Fluid‑filled vesicles or pustules on the skin of the lid, often resembling a cold sore.
• Crusting or “scab” formation after vesicles rupture.
• Tenderness or itching around the lid.

Conjunctiva (herpes conjunctivitis)

• Redness of the white part of the eye.
• Watery or mucous discharge.
• Soreness or a gritty sensation.
• Swelling of the conjunctival fornix.

Cornea (herpes keratitis)

• Eye pain ranging from mild irritation to severe throbbing.
• Blurred or decreased vision.
• Photophobia (light sensitivity).
• Feeling of a foreign body in the eye.
• Characteristic dendritic (branch‑like) ulcer visible on fluorescein staining.
• In recurrent disease, stromal infiltrates or scarring leading to permanent visual loss.

Uvea (herpes uveitis)

• Deep, aching ocular pain.
• Floaters and decreased visual acuity.
• Redness of the iris and ciliary body.
• Possible hypopyon (pus in the anterior chamber) in severe cases.

Other systemic clues

• History of oral herpes (cold sores) or genital herpes.
• Fever or malaise during primary infection.

Causes and Risk Factors

What causes ophthalmic herpes simplex?

HSV is a DNA virus that establishes lifelong latency in sensory ganglia (primarily the trigeminal ganglion for facial sites). Reactivation can occur spontaneously or be triggered by external factors, allowing the virus to travel down the ophthalmic branch of the trigeminal nerve to the eye.

Key risk factors

• Previous HSV infection: Most ocular cases occur in people who already carry the virus elsewhere (mouth or genitals).
• Immunosuppression: HIV/AIDS, chemotherapy, long‑term corticosteroids, biologic agents.
• Physical or emotional stress: Stress hormones can reactivate latent virus.
• UV light exposure: Sunlight, especially without protective eyewear, is a well‑documented trigger for corneal recurrences.
• Trauma or surgery: Corneal abrasions, LASIK, or other ocular procedures can precipitate infection.
• Contact lens wear: Poor hygiene may facilitate viral spread, though bacterial infections are more common.
• Hormonal changes: Pregnancy and menstrual cycle fluctuations have been linked to increased recurrence rates.

Diagnosis

Timely, accurate diagnosis is essential to prevent vision‑threatening complications.

Clinical examination

• Slit‑lamp biomicroscopy: Allows the clinician to view characteristic dendritic or geographic corneal lesions after fluorescein dye staining.
• Rose bengal or lissamine green staining: Highlights damaged epithelial cells.
• Inspection for eyelid vesicles, conjunctival injection, and stromal infiltrates.

Laboratory tests

• Polymerase chain reaction (PCR): Highly sensitive detection of HSV DNA from corneal scrapings or tear fluid. Preferred when the presentation is atypical.
• Viral culture: Less commonly used now because it is slower and less sensitive than PCR.
• Serology: Detects HSV‑specific IgG/IgM but does not differentiate ocular involvement; mainly useful for epidemiologic studies.
• In vivo confocal microscopy: Can visualize viral particles and inflammatory cells in the cornea, useful in research settings.

Differential diagnosis

Other conditions that may mimic HSE include bacterial or fungal keratitis, allergic conjunctivitis, autoimmune keratitis (e.g., Mooren ulcer), and ocular rosacea. Accurate identification prevents inappropriate steroid use, which can worsen HSV infection.

Treatment Options

Treatment aims to eradicate active viral replication, reduce inflammation, and prevent scarring. Therapy is usually a combination of systemic and topical agents, with occasional procedural interventions.

Antiviral Medications

• Topical acyclovir 3% ointment: Applied five times daily for 7–10 days; useful for epithelial disease.
• Topical ganciclovir 0.15% gel: FDA‑approved for herpes keratitis; applied five times daily.
• Oral antivirals (first‑line):
  • Acyclovir 400 mg five times daily
  • Valacyclovir 500 mg three times daily
  • Famciclovir 250 mg three times daily
  Treatment courses range from 7–10 days for primary infection to 5‑7 days for recurrences.
• Long‑term suppressive therapy: For frequent recurrences (≥ 2 episodes/year), daily oral valacyclovir 500 mg is recommended to reduce breakthrough risk by up to 70% [Cleveland Clinic].

Adjunctive Therapies

• Topical corticosteroids: Indicated only for stromal keratitis or uveitis after antiviral coverage is established. Must be tapered slowly under close supervision to avoid exacerbating viral replication.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Occasionally used for pain and inflammation, but with caution due to risk of corneal melting.
• Lubricating eye drops/artificial tears: Help soothe surface irritation and maintain epithelial healing.

Procedural Interventions

• Debridement: Mechanical removal of necrotic epithelium can enhance penetration of topical antivirals in severe epithelial disease.
• Phototherapeutic keratectomy (PTK): Laser removal of superficial stromal scarring when vision is compromised.
• Corneal transplantation (penetrating keratoplasty): Reserved for advanced stromal scarring or thinning unresponsive to medical therapy.

Lifestyle and Supportive Measures

• Strict hand hygiene; avoid touching eyes with contaminated hands.
• Use of protective sunglasses to block UV light.
• Discontinue contact lens wear during active infection.
• Manage systemic triggers (stress, illness) with general health measures.

Living with Ophthalmic Herpes Simplex

Chronic management focuses on controlling recurrences while preserving vision.

Daily management tips

• Medication adherence: Keep a medication diary or set alarms to ensure full course completion.
• Eye hygiene: Use separate towels for the face; wash pillowcases frequently.
• Cold‑sore vigilance: Treat oral herpes promptly; an active oral lesion increases ocular risk.
• Routine eye exams: At least once every 6–12 months, or sooner if symptoms recur.
• Stress reduction: Incorporate relaxation techniques—mindfulness, yoga, regular exercise.
• UV protection: Wear wrap‑around sunglasses with 100% UVA/UVB protection; consider a hat.
• Nutrition: Adequate vitamin A and omega‑3 fatty acids support corneal health.

Psychosocial aspects

Recurrent eye disease can cause anxiety about vision loss. Counseling, support groups, and patient education improve coping and medication compliance.

Prevention

• Primary prevention: Avoid direct contact with active HSV lesions on the lips or genitals; do not share towels, lip balm, or eye makeup.
• Vaccination research: No approved HSV vaccine yet, but clinical trials are ongoing (e.g., HSV-2 subunit vaccine). Stay informed about future developments.
• Suppressive antiviral therapy: As noted, daily valacyclovir or famciclovir markedly reduces recurrence rates.
• UV‑blocking eyewear: Wear sunglasses outdoors; consider UV‑blocking contact lens coatings if lenses are used.
• Prompt treatment of oral/genital outbreaks: Early antiviral therapy curtails viral load and reduces ocular seeding.

Complications

If left untreated or inadequately managed, ophthalmic HSV can lead to serious, sometimes irreversible, ocular damage.

• Corneal scarring (stromal opacity): The most common cause of permanent visual impairment.
• Corneal neovascularization: New blood vessels grow into the cornea, compromising transparency.
• Recurrent epithelial erosions: Persistent pain and reduced vision.
• Endothelial dysfunction: Leads to corneal edema and bullous keratopathy.
• Secondary bacterial or fungal infection: Damaged epithelium predisposes to superinfection.
• Vision loss: In severe stromal keratitis or uveitis, visual acuity can fall below 20/200.
• Glaucoma: Chronic inflammation can increase intra‑ocular pressure.
• Sympathetic ophthalmia: Rare bilateral granulomatous uveitis after severe ocular injury.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. Herpes Simplex Virus (HSV) Infection. Updated 2023.
• Mayo Clinic. Herpes Eye Infection. Accessed May 2024.
• Cleveland Clinic. Herpes Simplex Keratitis. Reviewed 2023.
• World Health Organization. Herpes Simplex Virus Fact Sheet. 2022.
• American Academy of Ophthalmology. Herpes Simplex Keratitis. Clinical practice guideline, 2021.
• National Institutes of Health, National Eye Institute. Herpes Keratitis. 2022.

```